Psst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveCLEATUS Webinar: AI for Government Contracting — Free Webinar — Wednesday, September 30 at 2:00 PM EDT

Register Free →

Search

Top

Back to Contracts

Pharmaceutical Manufacturing (Methylphenidate ER)

Active

Federal

Response Deadline10/23/2026, 05:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

This subcontract involves the pharmaceutical manufacturing of Methylphenidate ER 36 MG Tablets to support prime contractors on supply projects for the DLA and VA. The scope of work encompasses the chemical synthesis and formulation of extended-release medication, utilizing specialized delivery equipment and pharmaceutical grade facilities. All production must maintain full compliance with FDA cGMP standards to ensure the quality and safety of the bulk quantities delivered. Managed by the Department of Defense under the Medical Supply Chain FSGB, the project falls under NAICS code 325412. The solicitation was posted on September 23, 2026, with a response deadline of October 23, 2026.

General Info

Pharmaceutical manufacturing of Methylphenidate ER 36 MG Tablets for DLA and VA projects.

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN FSGBView Agency

NAICS

325412 - Pharmaceutical Preparation ManufacturingView NAICS

Place of Performance

USA

Set-Aside

NONE

Documents

This scope was carved out of SPE2D2-26-R-0013.

The full solicitation package (3 documents), including the RFP, is on the prime solicitation, not on this scope.

View the prime solicitation

PHARM MANUF/DISTR DIV - FSA

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

PostedSep 23

subcontract

Response DeadlineOct 23

Submission deadline

Response Deadline

10/23/2026, 05:00:00 PM UTCin 30 days

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more

AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN FSGB

ContactsNo contacts available

OfficeN/A

Organization / Agency

Department Of Defense → MEDICAL SUPPLY CHAIN FSGB

View Agency Profile

Office AddressN/A

ContactsNo contact information available

Full Description

Show more

Manufactures Methylphenidate ER 36 MG Tablets for prime contractors on DLA and VA pharmaceutical supply projects. Performs chemical synthesis and formulation of extended-release medication using pharmaceutical grade manufacturing facilities and specialized ER delivery equipment. Requires full compliance with FDA cGMP standards. Delivers bulk quantities of Methylphenidate ER 36 MG Tablets.

Similar Contracts

Same NAICS industry code

Supply of Dibucaine Ointment (NSN 6505-00-299-9535)This subcontract involves the supply of 3,000 packages of 1% dibucaine rectal ointment for prime contractors supporting DLA Troop Support medical supply contracts. The pharmaceutical products must meet specific active ingredient concentrations and be packaged in 1 ounce or 28 gram collapsible tubes equipped with rectal applicators. All supplies must comply with pharmaceutical manufacturing and distribution standards for NSN 6505-00-299-9535. The contract is managed by the Department of Defense under the Medical Supply Chain Pharm FSA, with the place of performance located at FPO 09573. Falling under NAICS code 325412, the opportunity was posted on September 23, 2026, with a response deadline of September 29, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 10 hours ago

DEADLINE

Apraclonidine Hydrochloride Ophthalmic Solution ManufacturingThis subcontract involves the pharmaceutical manufacturing of 1% Apraclonidine Hydrochloride Ophthalmic Solution to support prime contractors delivering medical supplies to DLA Troop Support. The selected provider is responsible for the chemical synthesis and formulation of the solution to pharmaceutical grade specifications, requiring the use of API Apraclonidine Hydrochloride and specialized manufacturing facilities. To ensure quality and safety, the manufacturer must maintain active FDA registration and adhere to current good Manufacturing Practice compliance. The final deliverable is the finished ophthalmic solution, with performance taking place in San Antonio, Texas, under the oversight of the Department of Defense Medical Supply Chain Pharm FSA.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 10 hours ago

DEADLINE

Supply of Potassium Iodide Tablets (130mg)This subcontract through the Department of Defense Medical Supply Chain Pharm FSA involves the supply of 130mg Potassium Iodide tablets for prime contractors. The requirement specifies the delivery of 24 packages, each containing 14 tablets in foil-sealed units, to be performed at Tyndall Air Force Base. All products must adhere to a non-extendable shelf life of 120 months as per NSN 6505-01-496-4916 and be maintained at temperatures between 68 and 77 degrees Fahrenheit. To qualify, providers must hold the necessary pharmaceutical manufacturing licenses and maintain full FDA compliance. The opportunity was posted on September 23, 2026, with a response deadline of September 29, 2026. This procurement falls under NAICS code 325412 for pharmaceutical preparation.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 10 hours ago

DEADLINE

Supply of Moxifloxacin Hydrochloride Tablets (400 MG)This subcontract involves the supply of pharmaceutical-grade Moxifloxacin Hydrochloride Tablets, 400 MG, for prime contractors supporting MEDICAL SUPPLY CHAIN PHARM FSA projects under the Department of Defense. The provider is responsible for manufacturing or sourcing the medication ensuring exact dosage and utilizing GMP-compliant facilities with climate-controlled storage to prevent humidity damage. All products must adhere to FDA and GMP standards, as well as RP001 DLA Packaging Requirements, with delivery specified in bottles of 30 units each. The opportunity is categorized under NAICS code 325412 and is associated with a place of performance in FPO 09591. The solicitation was posted on September 23, 2026, with a response deadline of September 29, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 10 hours ago

DEADLINE

Supply of Dextrose Oral Gel (15g Packages)This subcontract involves the supply of pharmaceutical-grade Dextrose Oral Gel in 15g packages for prime contractors supporting the Department of Defense Medical Supply Chain Pharm FSA. The provider is responsible for manufacturing or sourcing the product to ensure a total shelf life of 18 months, with a strict requirement that no more than 15 months pass between the date of manufacture and delivery. All deliverables must strictly adhere to DLA Packaging Requirements RP001 and General Technical and Quality Requirements RA001. The contract specifies delivery to designated DLA locations, with the place of performance centered in Groton, Massachusetts. This procurement falls under NAICS code 325412 and is managed through the DLA Troop Support Medical Supply Chain.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 10 hours ago

DEADLINE

Pharmaceutical Packaging and LabelingThis subcontract for the Department of Defense Medical Supply Chain FSGB involves the final packaging and labeling of Methylphenidate ER 36 MG Tablets for prime contractors supporting DLA and VA pharmaceutical supply projects. The scope of work requires bottling tablets into 100-count pharmaceutical bottles and applying labels that adhere to strict government and FDA specifications using automated bottling and labeling lines. All operations must be conducted in full compliance with FDA cGMP standards to ensure pharmaceutical quality and safety. The contract falls under NAICS code 325412 and was posted on September 23, 2026, with a response deadline of October 23, 2026.

MEDICAL SUPPLY CHAIN FSGB

POSTED

about 10 hours ago

DEADLINE

DIBUCAINE OINTMENT

Solicitation # SPE2DP-26-T-5207

Solicitation SPE2DP-26-T-5207 is a fixed-price request for quotations issued by the DLA Troop Support Medical Supply Chain Pharm FSA for the procurement of Dibucaine Ointment, NSN 6505002999535. The requirement is for three packages of the ointment, which must contain 1 percent of dibucaine as the active ingredient and be supplied in a collapsible tube with a rectal applicator. Each unit of issue is defined as one ounce or 28 grams. The product must meet USP standards and be stored between 15 to 30 degrees Celsius. The item has a non-extendable shelf life of 36 months. Delivery is set as FOB Destination to the USNS Henson T AGS 63 in FPO AE 09573, with an original required delivery date of September 25, 2026, and a lead time of 20 days. Inspection and acceptance will occur at the destination. Packaging must comply with RP001 DLA requirements, MIL-STD-129 for marking, and Medical Marking Standard No. 1. If the material is deemed hazardous per FED-STD-313, it must follow TQ requirement IP025; otherwise, it should be commercially packaged per ASTM D3951. Quotations must be submitted via the DIBBS system by September 29, 2026. The contract incorporates various FAR and DFARS clauses, including those regarding the Buy American Act, safeguarding covered defense information, and the use of the Wide Area WorkFlow system for invoicing.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 10 hours ago

DEADLINE

TOLNAFTATE POWDER

Solicitation # SPE2DP-26-T-5209

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 10 hours ago

DEADLINE

DETERGENT, SURGICAL

Solicitation # SPE2DP-26-T-5210

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 10 hours ago

DEADLINE

MOXIFLOXACIN HYDROC

Solicitation # SPE2DP-26-T-5203

Solicitation SPE2DP-26-T-5203 is a Request for Quotations issued by the DLA Troop Support Medical Supply Chain for the procurement of Moxifloxacin Hydrochloride 400 mg tablets. The items are supplied in bottles containing 30 tablets each, with the bottle serving as the unit of issue. The procurement includes multiple line items with quantities ranging from 3 to 14 bottles. The drug is FDA-regulated and must be stored at controlled room temperature, avoiding high humidity. It carries a non-extendable shelf life of 36 months and must be marked according to Medical Marking Standard No. 1. Delivery is required within 20 days of order, with FOB Destination terms. Shipments are destined for various locations, including the USS Lewis B Puller and USS Sampson, as well as facilities in North Carolina and Kentucky. Packaging must comply with DLA Master List of Technical and Quality Requirements, ASTM D3951 for non-hazardous materials, and RP001 for palletization. Invoicing and receiving reports must be processed electronically through the Wide Area WorkFlow system. The solicitation is categorized under NAICS 325412 and incorporates various FAR and DFARS clauses regarding cybersecurity, domestic preferences, and the safeguarding of covered defense information.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 10 hours ago

DEADLINE

PHARM MANUF/DISTR DIV - FSA

Solicitation # SPE2D2-26-R-0013

Solicitation SPE2D2-26-R-0013 is issued by the Defense Logistics Agency (DLA) Troop Support for the procurement of Methylphenidate ER tablets in 100 count bottles. The requirement covers three specific strengths: 27 MG (25,512 bottles), 36 MG (35,111 bottles), and 54 MG (18,708 bottles). This is a lowest price technically acceptable (LPTA) acquisition, where the award will be granted to the responsible offeror who meets the technical and past performance requirements and provides the lowest evaluated aggregate price. The contract structure includes a base year and four option years, requiring offerors to provide pricing for all periods in U.S. dollars as a unit price per box. The contractor must adhere to strict manufacturing and packaging standards, including FDA current Good Manufacturing Practices (cGMP) and the Drug Supply Chain Security Act. Packaging requirements specify a minimum 100cc bottle volume with a child-proof closure and specific dimensions to ensure compatibility with automated dispensing units like Baxter ATC Canisters and OptiFill. Bar coding must follow ANSI/ISO/IEC quality grade C or better and be placed in ladder orientation on bottles or on each cell of blister packs. Deliveries must be made to PPV distribution centers within 15 calendar days of order receipt, and the awardee must establish business-to-business agreements with DLA and VA PPV contractors. Proposals must be submitted electronically via the DIBBS portal by October 23, 2026, at 3:00 PM ET, consisting of a non-price technical volume and a price proposal. Evaluation is based on technical acceptability and past performance, with a requirement for FDA-approved products to have a Therapeutic Equivalence Code of A unless all family group drugs are B rated. The solicitation also incorporates various FAR and DFARS clauses, including those regarding trade agreements and the secondary Arab boycott of Israel.

MEDICAL SUPPLY CHAIN FSGB

POSTED

about 10 hours ago

DEADLINE

GLOBULIN, RHO (D) IMMUN

Solicitation # SPE2DP-26-T-5205

Solicitation SPE2DP-26-T-5205 is a request for quotations issued by the DLA Troop Support Medical Supply Chain Pharm FSA for the procurement of two units of Globulin, Rho (D) Immune (NSN 6505-01-417-1250). The required product must meet USP standards, be provided as an adult dose of 300 mcg in a disposable 1ml syringe with safety for intramuscular injection, and must be stored at 2-8 degrees Celsius without freezing. The delivery is required within 20 days after the order, with the shipping destination specified as the USS Fitzgerald (DDG 62) in FPO AP 96665. The contract mandates strict adherence to hazardous materials regulations, requiring a current Material Safety Data Sheet (MSDS) and packaging that complies with 49 CFR, ICAO, and IMDG standards. All packaging and labeling must follow MIL-STD-129 and Medical Marking Standard No. 1. Administrative requirements include the use of the Wide Area WorkFlow (WAWF) system for invoicing and compliance with the Buy American and Balance of Payments Program. Quotations must be submitted via the DIBBS portal by September 29, 2026, and the government will perform both inspection and acceptance at the destination.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 10 hours ago

DEADLINE

More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN FSGB

Same awarding agency

Pharmaceutical Distribution and LogisticsThis subcontract for Pharmaceutical Distribution and Logistics, managed by the Department of Defense Medical Supply Chain FSGB, involves the supply and transport of finished pharmaceutical products for prime contractors on DLA and VA supply contracts. The selected provider is responsible for the warehousing and delivery of order quantities to VA Prime Vendor contractors, ensuring all shipments are completed within 15 calendar days. To maintain product integrity, the contractor must utilize climate-controlled storage and transport vehicles while strictly adhering to all pharmaceutical transport regulations. The scope of work focuses on the secure delivery of products to designated PPV contractors under NAICS code 424110.

Printing and Writing Paper Merchant Wholesalers

POSTED

about 10 hours ago

DEADLINE

PHARM MANUF/DISTR DIV - FSA

Solicitation # SPE2D2-26-R-0012

Solicitation SPE2D2-26-R-0012 is a requirements contract issued by the Defense Logistics Agency Troop Support Medical Supply Chain for the procurement of Febuxostat tablets in 40mg and 80mg strengths, provided in 30-count bottles. The acquisition is categorized under NAICS code 325412 and is open to responsible offerors who are technically acceptable and provide the lowest evaluated aggregate price. Technical evaluation is based on compliance with the statement of work and a review of past performance, including the status of FDA warning letters and inspection disclosures. Proposals must be submitted electronically via the DIBBS portal by September 24, 2026, at 3:00 PM Philadelphia time, organized into non-price and price proposal volumes. The contract mandates strict adherence to FDA current Good Manufacturing Practices and requires that products possess an FDA-approved New Drug Application or abbreviated NDA, generally requiring a Therapeutic Equivalence Code of A. Packaging must be compatible with automated dispensing units, featuring a cylindrical non-glass bottle of at least 100cc with a child-proof closure. Detailed labeling requirements include unit-of-use bar coding with GS1-128, GS1 DataBar, or UPC symbology, and compliance with the Drug Supply Chain Security Act for traceability. Payment is structured through business-to-business agreements with Prime Vendor contractors rather than direct government payment, and offerors must identify the country of origin for both end products and active pharmaceutical ingredients.

Pharmaceutical Preparation Manufacturing

POSTED

DEADLINE

PHARM MANUF/DISTR DIV - FSA

Solicitation # SPE2D2-26-R-0015

Solicitation SPE2D2-26-R-0015 is a requirements contract issued by the Defense Logistics Agency (DLA) Troop Support to establish a national supply source for Progesterone 100MG and 200MG capsules. The contract is designed to support the Pharmaceutical Prime Vendor (PPV) programs for the DLA and Department of Veterans Affairs, ensuring product availability and volume-based pricing for DoD, VA, Bureau of Prisons, and Indian Health Service customers. The award will consist of a one-year base period with four optional one-year extensions, for a maximum term of five years. A unique payment structure is utilized where the awarded contractor enters into business-to-business agreements with PPV contractors, who handle the distribution and payment rather than the government paying the manufacturer directly. The contractor must adhere to strict pharmaceutical standards, including FDA current Good Manufacturing Practices (cGMP) and the Drug Supply Chain Security Act. Technical requirements specify that products must be FDA-approved with a Therapeutic Equivalence Code of A, unless all family group drugs are rated B. Packaging must feature child-proof closures, specific bottle dimensions, and high-quality GS1-128 or HIBC bar coding. The solicitation is open to small businesses, including HUBZone, service-disabled veteran-owned, and women-owned small businesses. Evaluation is based on technical acceptability, past performance, and the lowest evaluated aggregate price. Following several amendments, the final closing date for the receipt of offers was extended to October 2, 2026.

Drugs and Druggists' Sundries Merchant Wholesalers

POSTED

DEADLINE

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Join 750+ contractors already using CLEATUS